Clinical Trial Update: Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or Carbamazepine

View source ↗

Summary

This clinical trial update describes developmental outcomes in children exposed in utero to lamotrigine, sodium valproate, or carbamazepine, including autism sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Congenital Anomalies
• Developmental Delay

Drugs mentioned

• Carbamazepine (Carbamazepine)
• Lamotrigine (lamotrigine)
• Sodium valproate (valproate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism, Developmental Delay | Status: UNKNOWN